Comparison between full dose and reduced dose enoxaparin in the management of cancer-associated venous thromboembolism - report from ISTH2022 episode artwork

EPISODE · Jul 25, 2022 · 5 MIN

Comparison between full dose and reduced dose enoxaparin in the management of cancer-associated venous thromboembolism - report from ISTH2022

from Medical Digest & Congress Report · host Medical Congress News

We asked Dr. Emma Leitinger about their work which was presented as a poster at the recent ISTH 2022 congress. Video: https://congressreport.eu/scientific-contents/interview:comparison-between-full-dose-and-reduced-dose-enoxaparin-management-cancer-associated-venous-thromboembolism

Episode metadata supplied by the publisher feed · Published Jul 25, 2022

Embed this episode

Ready to play

Comparison between full dose and reduced dose enoxaparin in the management of cancer-associated venous thromboembolism - report from ISTH2022

0:00 5:04

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 5 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on July 25, 2022.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!